Abstract 4596: Targeting arginine methylome in 9p21/MTAP-deleted malignant cancers with a next generation PRMT5-specific inhibitor CTS3497

蛋白质精氨酸甲基转移酶5 癌症研究 癌症 精氨酸 甲基化 医学 甲基转移酶 生物 遗传学 内科学 基因 氨基酸
作者
Yilin Liu,Long Wang,Hui Shi,Yuanyuan Liu,Qiugeng Ouyang,Xingnian Fu,Meng Wang,Jiannan Guo,Yiqin Wang,Youzhen Wang,Guoliang Xu,Yuan Mi,Haiping Wu
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 4596-4596
标识
DOI:10.1158/1538-7445.am2024-4596
摘要

Abstract It remains largely challenging to treat cancer patients with chromosome 9p21-deletion which occurs in approximately 15% of human cancers. Recently, specific targeting of protein arginine methyltransferase 5 (PRMT5), a key member of the type-II PRMT family and a master epigenetic modulator of arginine methylome essential for cancer progression, has emerged as a promising therapy in various hematological and solid tumors with MTAP deletion serving as a precision biomarker. To optimize the potential of targeting PRMT5, we developed CTS3497, a potent, brain-penetrable, orally bioavailable MTA-cooperative PRMT5 inhibitor, using our EpigenPLUSTM platform. The overall excellent drug-like properties of CTS3497 support fast track IND application, and it is anticipated to enter Phase 1 trials in 2024. CTS3497 demonstrated potent PRMT5 inhibitory activity in cellular pharmacodynamics (PD) assays, evidenced by the suppression of symmetric dimethylarginine (SDMA). Additionally, it exhibited profound cell growth inhibition with a low single-digit nM IC50 and 171-fold high selectivity for MTAPnull over isogenic MTAPwt cell lines. Moreover, CTS3497 displayed strong inhibitory effects on cell growth across diverse panels of MTAPnull cancer cell lines and patient-derived xenograft organoids (PDXOs) spanning various lineages. In vivo, oral administration of CTS3497 resulted in significant tumor regression in multiple MTAP-deleted xenograft models, notably MTAPnull brain tumors. The observed anti-tumor activity correlated with PRMT5 modulation, as indicated by reduced SDMA levels. Impressively, sustained tumor growth inhibition led to the complete tumor regression, with no regrowth even after discontinuation of CTS3497 treatment. The brain penetration property of CTS3497 underscores its therapeutic potential for both primary brain tumors, and brain metastases arising from specific cancers like lung cancer. At the molecular level, PRMT5 inhibition by CTS3497 induced substantial and distinctive RNA splicing defects and differentially expressed gene signatures, impacting key cellular activities downstream of arginine and epigenetic reprogramming in MTAPnull cancer cells. Furthermore, a synergistic anti-tumor effect was observed in multiple MTAP-deleted tumors when combining PRMT5 inhibition with CTS2190, an investigational type-I PRMT inhibitor currently in phase I/II clinical trials. In summary, CTS3497, a PRMT5 inhibitor selectively targeting MTAPnull tumor cells, demonstrated robust and durable anti-tumor responses both in vitro and in vivo across diverse lineages of MTAP-deleted tumors. Its superior ADME properties and favorable safety profiles observed in preclinical studies mark a breakthrough in the next generation epigenetic therapy. CTS3497 emerges as a promising therapeutic option for patients with MTAP-deleted malignancies. Citation Format: Yilin Liu, Long Wang, Hui Shi, Yuanyuan Liu, Qiugeng Ouyang, Xingnian Fu, Meng Wang, Jiannan Guo, Yiqin Wang, Youzhen Wang, Guoliang Xu, Yuan Mi, Haiping Wu. Targeting arginine methylome in 9p21/MTAP-deleted malignant cancers with a next generation PRMT5-specific inhibitor CTS3497 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4596.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助sasa采纳,获得10
刚刚
Jin完成签到,获得积分10
刚刚
海豚完成签到,获得积分10
刚刚
乐乐应助plu采纳,获得10
1秒前
清浼完成签到,获得积分10
1秒前
健康富裕发布了新的文献求助10
1秒前
1秒前
业余的s完成签到,获得积分10
1秒前
feifei发布了新的文献求助10
1秒前
ssk发布了新的文献求助10
1秒前
2秒前
2秒前
如意问丝完成签到,获得积分10
2秒前
妥妥酱发布了新的文献求助10
3秒前
WTC发布了新的文献求助10
4秒前
所所应助呜呜呜采纳,获得10
5秒前
5秒前
开心千青发布了新的文献求助10
5秒前
5秒前
5秒前
务实铅笔发布了新的文献求助10
6秒前
谷策发布了新的文献求助10
6秒前
6秒前
6秒前
哈利波特完成签到,获得积分10
6秒前
大大大长腿完成签到,获得积分10
6秒前
友好若南发布了新的文献求助10
7秒前
xr发布了新的文献求助10
7秒前
nsk完成签到,获得积分10
8秒前
浅浅完成签到,获得积分20
8秒前
9秒前
zzzzzzzzzzzzx发布了新的文献求助10
9秒前
cmd完成签到,获得积分10
9秒前
超萌小小发布了新的文献求助10
9秒前
烟花应助合欢采纳,获得10
9秒前
9秒前
10秒前
稳重的鱼完成签到 ,获得积分10
11秒前
环环发布了新的文献求助10
11秒前
boxmove完成签到,获得积分20
11秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Semiconductor Process Reliability in Practice 720
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3227124
求助须知:如何正确求助?哪些是违规求助? 2875291
关于积分的说明 8190203
捐赠科研通 2542475
什么是DOI,文献DOI怎么找? 1372802
科研通“疑难数据库(出版商)”最低求助积分说明 646537
邀请新用户注册赠送积分活动 620971